BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24375192)

  • 1. The upregulation of programmed death 1 on peripheral blood T cells of glioma is correlated with disease progression.
    Wei B; Wang L; Zhao X; Du C; Guo Y; Sun Z
    Tumour Biol; 2014 Apr; 35(4):2923-9. PubMed ID: 24375192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of programmed death 1 is correlated with progression of osteosarcoma.
    Zheng W; Xiao H; Liu H; Zhou Y
    APMIS; 2015 Feb; 123(2):102-7. PubMed ID: 25257510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic CD4
    Ge J; Zhao L; Li G; White J; Song Z; Wang Z; Zhao L
    Int J Neurosci; 2017 May; 127(5):386-395. PubMed ID: 27167139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis.
    Li S; Liao W; Chen M; Shan S; Song Y; Zhang S; Song H; Yuan Z
    Inflammation; 2014 Feb; 37(1):116-21. PubMed ID: 24062057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
    Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
    Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
    Front Immunol; 2018; 9():727. PubMed ID: 29910795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.
    Fernandez SV; MacFarlane AW; Jillab M; Arisi MF; Yearley J; Annamalai L; Gong Y; Cai KQ; Alpaugh RK; Cristofanilli M; Campbell KS
    Breast Cancer Res; 2020 Dec; 22(1):134. PubMed ID: 33267869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
    Wei J; Nduom EK; Kong LY; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C; Fuller GN; Gilbert MR; Overwijk W; Calin GA; Heimberger AB
    Neuro Oncol; 2016 May; 18(5):639-48. PubMed ID: 26658052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
    Garber ST; Hashimoto Y; Weathers SP; Xiu J; Gatalica Z; Verhaak RG; Zhou S; Fuller GN; Khasraw M; de Groot J; Reddy SK; Spetzler D; Heimberger AB
    Neuro Oncol; 2016 Oct; 18(10):1357-66. PubMed ID: 27370400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer.
    Shen T; Zhou L; Shen H; Shi C; Jia S; Ding GP; Cao L
    Sci Rep; 2017 Aug; 7(1):7848. PubMed ID: 28798308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
    Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus].
    Wang Y; Xie C; Sun M; Chai J; Zhou Y; Chen Y; Tang J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):962-5. PubMed ID: 24011159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma.
    Hölzl D; Hutarew G; Zellinger B; Schlicker HU; Schwartz C; Winkler PA; Sotlar K; Kraus TFJ
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2271-2280. PubMed ID: 33963441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.
    Shimauchi T; Kabashima K; Nakashima D; Sugita K; Yamada Y; Hino R; Tokura Y
    Int J Cancer; 2007 Dec; 121(12):2585-90. PubMed ID: 17721918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells.
    Han H; Fu X; Huang J; Zhang X; Yu J
    J Toxicol Sci; 2020; 45(11):701-711. PubMed ID: 33132244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.
    Miyazaki T; Ishikawa E; Matsuda M; Akutsu H; Osuka S; Sakamoto N; Takano S; Yamamoto T; Tsuboi K; Matsumura A
    J Neurooncol; 2017 Jun; 133(2):277-285. PubMed ID: 28447277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
    Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
    J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.